Paper

Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform

Cross, Zachary, Haake, Bret C., Sase, Sunetra, Zhao, Ling, Fatemi, Ali, Walkiewicz, Marzena, Du, Yangzhu, Takanohashi, Asako, Woidill, Sarah, Waldman, Amy, Brenner, Michael, Sherbini, Omar, Perng, Ming D., Hagemann, Tracy L., Helman, Guy, Simons, Cas, Messing, Albee, Vanderver, Adeline

2019

Overview

Alexander disease results from gain of function mutations in the gene encoding glial fibrillary acidic protein (GFAP), an intermediate filament protein expressed in astrocytes. At least eight GFAP isoforms have been described, however, the predominant alpha isoform accounts for approximately 90% of GFAP protein in the central nervous system. Here we describe exonic variants identified in three unrelated families with Type II Alexander disease that alter the splicing of GFAP pre-mRNA and result in upregulation of a previously uncharacterized GFAP lambda isoform (NM 001363846.1). Affected members of Family 1 and Family 2 shared the same missense variant, NM 001363846.1:c.1289G>A;p.(Arg430His) while in Family 3 we identified a synonymous variant in the adjacent nucleotide, NM 001363846.1:c.1290C>A;p.(Arg430Arg). Using RNA and protein analysis of brain autopsy samples, and a mini-gene splicing reporter assay, we demonstrate both variants result in upregulation of the lambda isoform. We assessed other GFAP variants in the ClinVar database for predicted aberrant splicing and using the same assay demonstrated significant changes to splicing for two selected variants. Our approach demonstrates the importance of characterizing the effect of GFAP variants on mRNA splicing in order to inform future pathophysiologic and therapeutic study for Alexander disease.

• Publisher: Cold Spring Harbor Laboratory
• Subject: Genetics